Current and emerging treatments in the management of castration-resistant prostate cancer.

Current and emerging treatments in the management of castration-resistant prostate cancer.

Item
http://www.wikidata.org/entity/Q38030595
Molecular signaling involving intrinsically disordered proteins in prostate cancerVaccines for pancreatic cancerCurrent Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain.Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With EribulinGaleterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.Radium-223 for the treatment of prostate cancer.EZH2, an epigenetic driver of prostate cancer.Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions.Maintenance of androgen receptor inactivation by S-nitrosylation.
P2860

Current and emerging treatments in the management of castration-resistant prostate cancer.

Item
http://www.wikidata.org/entity/Q38030595
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current and emerging treatment ...... ion-resistant prostate cancer.
@en
type
label
Current and emerging treatment ...... ion-resistant prostate cancer.
@en
prefLabel
Current and emerging treatment ...... ion-resistant prostate cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Current and emerging treatment ...... ion-resistant prostate cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921